September 29, 2016 1:31 PM ET

Pharmaceuticals

Company Overview of Eli Lilly and Company

Executive Profile

Darren J. Carroll J.D.

Senior Vice President of Corporate Business Development, Eli Lilly and Company
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships
----

Background

Mr. Darren J. Carroll, J.D. has been Senior Vice President of Corporate Business Development at Eli Lilly and Company since January 1, 2015. Mr. Carroll leads the New Ventures Division of Eli Lilly and Company which includes both Lilly Ventures and Lilly Asian Ventures. Mr. Carroll serves as a Senior Managing Director at Lilly Asian Ventures. He served as the Vice President of New Ventures at Lilly Ventures. In this role at Lilly Ventures, Mr. Carroll oversees all private ...

Corporate Headquarters

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: --

Board Members Memberships

Chairman

Education

BA
Syracuse University
Master's Degree
The Maxwell School of Syracuse University
JD
Syracuse University College of Law

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$1.3M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$1.0M
Mark J. Alles Chief Executive Officer and Director
Celgene Corporation
$871.3K
Lars Rebien Sørensen Chief Executive Officer, President and Chairman of Operations Committee
Novo Nordisk A/S
$21.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Eli Lilly and Company, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.